Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albendazole versus praziquantel for Clonorchis sinensis infection
ISRCTN46268871Phase 2Completed
- Sponsor
- National Institute of Parasitic Diseases
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in clonorchiasis comparing Albendazole with Praziquantel (2 arms). Primary endpoints: Cure rate and Egg reduction rate. Started Mar 2025; status: completed.
02
Drugs
albendazolepraziquantel
03
Conditions
clonorchiasis
Beyond the preview
Go deeper on ISRCTN46268871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN46268871.